PREVENTION AND SCREENING OF CERVICAL CANCER

• Autor(a) principal: Bezerra, Rodrigo da Silva
• Data de Publicação: 2024
• Outros Autores: Diniz, Adriane Nunes, Soares, Lilian Josiane da Rosa, Minossi , Silvia Daniela, Macêdo, Laíza Cláudia Barbosa de, Beserra, Áthina Karla Vieira Nunes, Arruda, Allana Maria Newton, Carvalho, Juliana Ester Ribeiro, Sobral, Thierry Duarte Ribeiro, Sousa, Maria Kéren Ribeiro, Silva , Maria Alicia Moura, Lima, Maranna Paula Ferreira de, Ossani , Andreza
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Brazilian Journal of Implantology and Health Sciences
• Texto Completo: https://bjihs.emnuvens.com.br/bjihs/article/view/1272
• topic: Vacina, Prevenção, Ratreio, Câncer de colo de útero.; Vaccine, Prevention, Screening, Cervical cancer.

Cervical cancer (CC) is the fourth most common neoplasm and the fourth leading cause of cancer death among women worldwide, being responsible for approximately 570,000 new cases and 311,000 deaths in 2018. The objective of this article is to identify recent and relevant information available in the literature on CC prevention and screening. This is an integrative review with articles dated between 2018 and 2013 in the Lilacs, Scielo and Google Scholar databases. Vaccination against (HPV) is an important public health strategy to prevent CC. The vaccine offers a powerful tool to substantially reduce the burden of CC worldwide. The fundamental principle of cancer screening is the detection of the disease at an early, curable stage in the asymptomatic and apparently healthy population. The goal of uterine cancer screening is to detect high-grade lesions in asymptomatic women, treat them, and prevent progression to invasive disease. Prevention and screening strategies are excellent ways to mitigate the incidence and mortality of women with CC worldwide. However, this care is less in socioeconomically unfavorable countries, black women and women who live in rural areas.